Outcome prioritization and preferences among older adults with cancer starting chemotherapy in a randomized clinical trial

• Published in: Cancer Vol. 130; no. 17; pp. 3000 - 3010
• Main Authors: Soto‐Perez‐de‐Celis, Enrique, Dale, William, Katheria, Vani, Kim, Heeyoung, Fakih, Marwan, Chung, Vincent M., Lim, Dean, Mortimer, Joanne, Cabrera Chien, Leana, Charles, Kemeberly, Roberts, Elsa, Vazquez, Jessica, Moreno, Jeanine, Lee, Ty, Fernandes Dos Santos Hughes, Simone, Sedrak, Mina S., Sun, Can‐Lan, Li, Daneng
• Format: Journal Article
• Language: English
• Published: United States Wiley Subscription Services, Inc 01.09.2024
• Subjects: Adults; Aged; Aged, 80 and over; Attitudes; Cancer; Chemotherapy; Cognition; Decision making; Female; health priorities; Humans; Male; Metastases; Neoplasms - drug therapy; Neoplasms - psychology; older adults; Older people; Patient Preference; Quality of Life; Secondary analysis; shared; Survival; Treatment Outcome; patient preference; shared; health priorities; decision making; older adults; cancer; chemotherapy; treatment outcome
• ISSN: 0008-543X; 1097-0142; 1097-0142
• DOI: 10.1002/cncr.35333

Introduction Older adults with cancer facing competing treatments must prioritize between various outcomes. This study assessed health outcome prioritization among older adults with cancer starting chemotherapy. Methods Secondary analysis of a randomized trial addressing vulnerabilities in older adults with cancer. Patients completed three validated outcome prioritization tools: 1) Health Outcomes Tool: prioritizes outcomes (survival, independence, symptoms) using a visual analog scale; 2) Now vs. Later Tool: rates the importance of quality of life at three times—today versus 1 or 5 years in the future; and 3) Attitude Scale: rates agreement with outcome‐related statements. The authors measured the proportion of patients prioritizing various outcomes and evaluated their characteristics. Results A total of 219 patients (median [range] age 71 [65–88], 68% with metastatic disease) were included. On the Health Outcomes Tool, 60.7% prioritized survival over other outcomes. Having localized disease was associated with choosing survival as top priority. On the Now vs. Later Tool, 50% gave equal importance to current versus future quality of life. On the Attitude Scale, 53.4% disagreed with the statement “the most important thing to me is living as long as I can, no matter what my quality of life is”; and 82.2% agreed with the statement “it is more important to me to maintain my thinking ability than to live as long as possible”. Conclusion Although survival was the top priority for most participants, some older individuals with cancer prioritize other outcomes, such as cognition and function. Clinicians should elicit patient‐defined priorities and include them in decision‐making. In this secondary analysis of 219 older participants (median age 71 years) from a randomized trial addressing vulnerabilities in older adults with cancer, 61% prioritized survival over other outcomes such as maintaining their independence or being free from symptoms. Clinicians should elicit patient‐defined priorities and include them in decision‐making when discussing treatment.